Table 3. PPARγ immunohistochemistry in thyroid tumours.
|
PPARγ immunostaining |
|||
|---|---|---|---|
| Tissue | Negative | Positive | P-value |
| NT (n=47) | 11 (23%) | 36 (77%) | |
| NH (n=28) | 8 (29%) | 20 (71%) | NS |
| FTA (n=86) | 33 (38%) | 53 (62%) | NS |
| FTC (n=34) | 16 (47%) | 18 (53%) | 0.03 |
| PTC (n=39) | 20 (51%) | 19 (49%) | 0.01 |
| PDTC (n=13) | 13 (100%) | 0 | <0.0001 |
NS=not significant; NT=normal thyroid; NH=nodular hyperplasia; FTA=follicular thyroid adenoma; FTC=follicular thyroid carcinoma; PTC=papillary thyroid carcinoma; PDTC=poorly differentiated thyroid carcinoma; PPAR=peroxisome proliferator-activated receptor.